Semaglutide is generally recommended for adults who meet specific criteria, including having a BMI of 27 kg/m or greater with weight-related health conditions or a BMI of 30 kg/m or greater
By influencing neurotransmitter pathways, GLP-1 receptor agonists may help modulate dopamine and serotonin , two key players in mood and addiction regulation (Holst, 2021)
Tirzepatide: Tirzepatide targets both the GIP and GLP-1 receptors, providing a synergistic effect that enhances insulin secretion, slows gastric emptying, and reduces appetite
Certain proteins are particularly problematic
, a Daiichi Sankyo Group company, is an industry-leading injectable manufacturer
Public awareness of GLP-1 medications has also surged in recent years, with about 91% of respondents in 2026 reporting they knew the drugs could treat weight lossup from 80% in 2024